IRIS Accounts Production v26.1.10.61 08104785 Board of Directors 31.3.25 1.4.24 31.3.25 31.3.25 Medium entities These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. true true true false true true false false false false false true false Ordinary 0 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh081047852024-03-31081047852025-03-31081047852024-04-012025-03-31081047852022-09-30081047852022-10-012024-03-31081047852024-03-3108104785ns15:EnglandWales2024-04-012025-03-3108104785ns14:PoundSterling2024-04-012025-03-3108104785ns10:Director12024-04-012025-03-3108104785ns10:Consolidated2025-03-3108104785ns10:ConsolidatedGroupCompanyAccounts2024-04-012025-03-3108104785ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3108104785ns10:Consolidatedns10:MediumEntities2024-04-012025-03-3108104785ns10:Consolidatedns10:Audited2024-04-012025-03-3108104785ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-04-012025-03-3108104785ns10:Medium-sizedCompaniesRegimeForAccounts2024-04-012025-03-3108104785ns10:Consolidated2024-04-012025-03-3108104785ns10:Consolidatedns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-04-012025-03-3108104785ns10:Medium-sizedCompaniesRegimeForAccountsns10:Consolidated2024-04-012025-03-3108104785ns10:FullAccounts2024-04-012025-03-3108104785ns5:Subsidiary12024-04-012025-03-3108104785ns5:Subsidiary22024-04-012025-03-3108104785ns5:Subsidiary32024-04-012025-03-3108104785ns10:OrdinaryShareClass12024-04-012025-03-3108104785ns10:Director52024-04-012025-03-3108104785ns10:RegisteredOffice2024-04-012025-03-3108104785ns10:Director42024-04-012025-03-3108104785ns10:Director32024-04-012025-03-3108104785ns10:Director22024-04-012025-03-3108104785ns10:Consolidated2022-10-012024-03-3108104785ns5:CurrentFinancialInstruments2025-03-3108104785ns5:CurrentFinancialInstruments2024-03-3108104785ns5:Non-currentFinancialInstruments2025-03-3108104785ns5:Non-currentFinancialInstruments2024-03-3108104785ns5:ShareCapital2025-03-3108104785ns5:ShareCapital2024-03-3108104785ns5:RetainedEarningsAccumulatedLosses2025-03-3108104785ns5:RetainedEarningsAccumulatedLosses2024-03-3108104785ns5:ShareCapital2022-09-3008104785ns5:RetainedEarningsAccumulatedLosses2022-09-3008104785ns5:RetainedEarningsAccumulatedLosses2022-10-012024-03-3108104785ns5:RetainedEarningsAccumulatedLosses2024-04-012025-03-3108104785ns5:CostValuation2024-03-31081047851ns5:Subsidiary12024-04-012025-03-3108104785ns5:Subsidiary232024-04-012025-03-31081047855ns5:Subsidiary32024-04-012025-03-3108104785ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3108104785ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3108104785ns10:OrdinaryShareClass12025-03-31
REGISTERED NUMBER: 08104785 (England and Wales)
















Group Strategic Report, Report of the Directors and

Consolidated Financial Statements for the Year Ended 31 March 2025

for

Bio Collectors Holdings Limited

Bio Collectors Holdings Limited (Registered number: 08104785)






Contents of the Consolidated Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Group Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 5

Consolidated Income Statement 9

Consolidated Other Comprehensive Income 10

Consolidated Balance Sheet 11

Company Balance Sheet 12

Consolidated Statement of Changes in Equity 13

Company Statement of Changes in Equity 14

Consolidated Cash Flow Statement 15

Notes to the Consolidated Cash Flow Statement 16

Notes to the Consolidated Financial Statements 17


Bio Collectors Holdings Limited

Company Information
for the Year Ended 31 March 2025







DIRECTORS: S J Matthews
S J A Blackburn





REGISTERED OFFICE: 10 Osier Way
Mitcham
Surrey
CR4 4NF





REGISTERED NUMBER: 08104785 (England and Wales)





AUDITORS: Hardcastle Burton LLP
Lake House
Market Hill
Royston
Hertfordshire
SG8 9JN

Bio Collectors Holdings Limited (Registered number: 08104785)

Group Strategic Report
for the Year Ended 31 March 2025

The directors present their strategic report of the company and the group for the year ended 31 March 2025.

REVIEW OF BUSINESS
The results for the year and financial position of the group are as shown in the annexed financial statements.

The key financial highlights are as follows:


Year
Ended

Period
1.10.22 to
31.3.25 31.3.24
£'000000 £'000000
Turnover 10,441 18,167
Gross profit/(loss) (1,984 ) 1,586
Gross assets 10,992 11,791
Net assets 1,180 3,344

The group experienced a challenging financial year, with performance below the directors’ expectations. This was primarily driven by a combination of operational inefficiencies, cost inflation, and volatility in energy markets.

Despite these challenges, the group continued to benefit from the strategic alignment between its two operating segments, particularly through internal feedstock supply and reduced external costs. Management has taken steps during and subsequent to the year-end to address operational issues and improve overall efficiency.

The asset base remains strong, supported by the group’s investment in infrastructure. The directors are committed to improving returns on these assets through enhanced operational performance.

PRINCIPAL RISKS AND UNCERTAINTIES
The group continues to face a number of key risks, which the directors continually look out for and implement measures to mitigate these risks.

Operational performance risk
Reduced plant efficiency and fleet reliability can significantly impact results. The directors have taken steps after the year-end to enhance operational performance for the group.

Liquidity risk
The group has loans from its shareholders to support the cash flow requirements of the group. The group is expected to have sufficient cash resources to repay its creditors as they fall due, however the shareholders have indicated that financial support will be provided if required.

Regulatory risk
Changes in environmental or renewable energy policy may impact operations and profitability. Currently there are no known material risks that would impact the group's operations.

ON BEHALF OF THE BOARD:





S J Matthews - Director


21 May 2026

Bio Collectors Holdings Limited (Registered number: 08104785)

Report of the Directors
for the Year Ended 31 March 2025

The directors present their report with the financial statements of the company and the group for the year ended 31 March 2025.

PRINCIPAL ACTIVITIES
The principal activities of the group in the year under review were those of waste management and production of renewable energy.

DIVIDENDS
No dividends will be distributed for the year ended 31 March 2025.

DIRECTORS
The directors who have held office during the period from 1 April 2024 to the date of this report are as follows:

S J Matthews - appointed 20 July 2024
C Holmes - resigned 19 July 2024

S J A Blackburn was appointed as a director after 31 March 2025 but prior to the date of this report.

J B Williams and S Trivellato ceased to be directors after 31 March 2025 but prior to the date of this report.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Group Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the group's auditors are aware of that information.

Bio Collectors Holdings Limited (Registered number: 08104785)

Report of the Directors
for the Year Ended 31 March 2025


AUDITORS
The auditors, Hardcastle Burton LLP, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:




S J Matthews - Director


21 May 2026

Report of the Independent Auditors to the Members of
Bio Collectors Holdings Limited

Opinion
We have audited the financial statements of Bio Collectors Holdings Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 March 2025 which comprise the Consolidated Income Statement, Consolidated Other Comprehensive Income, Consolidated Balance Sheet, Company Balance Sheet, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Cash Flow Statement and Notes to the Consolidated Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the group's and of the parent company affairs as at 31 March 2025 and of the group's loss for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Group Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Group Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Report of the Independent Auditors to the Members of
Bio Collectors Holdings Limited


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
- the parent company financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

Report of the Independent Auditors to the Members of
Bio Collectors Holdings Limited


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Our approach was as follows:-

We obtained an understanding of the legal and regulatory frameworks that are applicable to the group and determined that the most significant frameworks which are directly relevant to specific assertions in the financial statements are those that related to the reporting framework (FRS 102 and Companies Act 2006) and the relevant tax compliance regulations in the jurisdictions that the company operates.

In addition, we concluded that there are certain significant laws and regulations which may have an effect on the determination of the amounts and disclosures in the financial statements being those relating to the environment and occupational health and safety.

We obtained an understanding to how the group is complying with those frameworks by making enquiries of management and those responsible for legal and compliance procedures. We corroborated our enquiries through our review of Board minutes and any correspondence received from regulatory bodies.

We assessed the susceptivity of the group's financial statements to material misstatement, including how fraud might occur by meeting with management from various parts of the business to understand the systems and controls of the group.

In assessing the risks of irregularities due to fraud, we considered the areas in which such risks were most likely to arise. We identified management override of controls as a presumed fraud risk and the valuation of tangible assets as the area most susceptible to material misstatement due to its inherent estimation uncertainty and the level of judgement involved.

Our audit procedures in response included:
- evaluating the methodologies, key assumptions and inputs used by management in the valuation of the tangible assets;
- assessing the reasonableness of significant estimates;
- considering indicators of management bias in the formulation of these estimates; and
- performing targeted journal entry testing.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Other matters
The consolidated comparative financial information presented for the period ended 31 March 2024 was derived from financial information of the group’s subsidiaries, the financial statements of which were audited individually in that period; however, consolidated financial statements were not prepared or audited. Accordingly, the comparative consolidated information presented in these financial statements does not constitute audited financial statements of the group.

Report of the Independent Auditors to the Members of
Bio Collectors Holdings Limited


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Kristi Johnson ACA CTA (Senior Statutory Auditor)
for and on behalf of Hardcastle Burton LLP
Lake House
Market Hill
Royston
Hertfordshire
SG8 9JN

22 May 2026

Bio Collectors Holdings Limited (Registered number: 08104785)

Consolidated
Income Statement
for the Year Ended 31 March 2025

Period
1.10.22
Year Ended to
31.3.25 31.3.24
Notes £    £   

TURNOVER 3 10,441,250 18,167,426

Cost of sales 12,425,654 16,581,183
GROSS (LOSS)/PROFIT (1,984,404 ) 1,586,243

Administrative expenses 495,740 513,121
(2,480,144 ) 1,073,122

Other operating income 485 17,220
OPERATING (LOSS)/PROFIT 5 (2,479,659 ) 1,090,342

Interest receivable and similar income 1,815 14,524
(2,477,844 ) 1,104,866

Interest payable and similar expenses 6 403,940 599,375
(LOSS)/PROFIT BEFORE TAXATION (2,881,784 ) 505,491

Tax on (loss)/profit 7 (717,647 ) 146,333
(LOSS)/PROFIT FOR THE FINANCIAL
YEAR

(2,164,137

)

359,158
(Loss)/profit attributable to:
Owners of the parent (2,164,137 ) 359,158

Bio Collectors Holdings Limited (Registered number: 08104785)

Consolidated
Other Comprehensive Income
for the Year Ended 31 March 2025

Period
1.10.22
Year Ended to
31.3.25 31.3.24
Notes £    £   

(LOSS)/PROFIT FOR THE YEAR (2,164,137 ) 359,158


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

(2,164,137

)

359,158

Total comprehensive income attributable to:
Owners of the parent (2,164,137 ) 359,158

Bio Collectors Holdings Limited (Registered number: 08104785)

Consolidated Balance Sheet
31 March 2025

31.3.25 31.3.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 10 7,381,168 7,347,958
Investments 11 - -
7,381,168 7,347,958

CURRENT ASSETS
Stocks 12 78,711 79,271
Debtors 13 2,741,484 3,944,145
Cash at bank 790,910 419,483
3,611,105 4,442,899
CREDITORS
Amounts falling due within one year 14 3,062,131 2,703,135
NET CURRENT ASSETS 548,974 1,739,764
TOTAL ASSETS LESS CURRENT
LIABILITIES

7,930,142

9,087,722

CREDITORS
Amounts falling due after more than one
year

15

(5,498,811

)

(3,859,902

)

PROVISIONS FOR LIABILITIES 18 (1,251,476 ) (1,883,828 )
NET ASSETS 1,179,855 3,343,992

CAPITAL AND RESERVES
Called up share capital 19 45,102 45,102
Retained earnings 20 1,134,753 3,298,890
SHAREHOLDERS' FUNDS 1,179,855 3,343,992

The financial statements were approved by the Board of Directors and authorised for issue on 21 May 2026 and were signed on its behalf by:





S J Matthews - Director


Bio Collectors Holdings Limited (Registered number: 08104785)

Company Balance Sheet
31 March 2025

31.3.25 31.3.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 10 - -
Investments 11 45,200 45,200
45,200 45,200

CURRENT ASSETS
Debtors 13 3,639,116 3,593,841

CREDITORS
Amounts falling due within one year 14 375,355 410,570
NET CURRENT ASSETS 3,263,761 3,183,271
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,308,961

3,228,471

CREDITORS
Amounts falling due after more than one
year

15

3,287,609

3,183,369
NET ASSETS 21,352 45,102

CAPITAL AND RESERVES
Called up share capital 19 45,102 45,102
Retained earnings 20 (23,750 ) -
SHAREHOLDERS' FUNDS 21,352 45,102

Company's (loss)/profit for the financial year (23,750 ) 400,000

The financial statements were approved by the Board of Directors and authorised for issue on 21 May 2026 and were signed on its behalf by:





S J Matthews - Director


Bio Collectors Holdings Limited (Registered number: 08104785)

Consolidated Statement of Changes in Equity
for the Year Ended 31 March 2025

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 October 2022 45,102 3,339,732 3,384,834

Changes in equity
Dividends - (400,000 ) (400,000 )
Total comprehensive income - 359,158 359,158
Balance at 31 March 2024 45,102 3,298,890 3,343,992

Changes in equity
Total comprehensive income - (2,164,137 ) (2,164,137 )
Balance at 31 March 2025 45,102 1,134,753 1,179,855

Bio Collectors Holdings Limited (Registered number: 08104785)

Company Statement of Changes in Equity
for the Year Ended 31 March 2025

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 October 2022 45,102 - 45,102

Changes in equity
Dividends - (400,000 ) (400,000 )
Total comprehensive income - 400,000 400,000
Balance at 31 March 2024 45,102 - 45,102

Changes in equity
Total comprehensive income - (23,750 ) (23,750 )
Balance at 31 March 2025 45,102 (23,750 ) 21,352

Bio Collectors Holdings Limited (Registered number: 08104785)

Consolidated Cash Flow Statement
for the Year Ended 31 March 2025

Period
1.10.22
Year Ended to
31.3.25 31.3.24
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 1,142,606 1,880,164
Interest paid (309,789 ) (477,605 )
Interest element of hire purchase payments
paid

(67,750

)

(86,786

)
Tax paid 100 30,774
Net cash from operating activities 765,167 1,346,547

Cash flows from investing activities
Purchase of tangible fixed assets (729,659 ) (1,286,179 )
Sale of tangible fixed assets - 3,001
Interest received 1,815 14,524
Net cash from investing activities (727,844 ) (1,268,654 )

Cash flows from financing activities
New loans in year 248,950 -
New HP contracts in year 509,540 847,315
Capital repayments on HP contracts (424,386 ) (329,059 )
Equity dividends paid - (400,000 )
Net cash from financing activities 334,104 118,256

Increase in cash and cash equivalents 371,427 196,149
Cash and cash equivalents at beginning of
year

2

419,483

223,334

Cash and cash equivalents at end of year 2 790,910 419,483

Bio Collectors Holdings Limited (Registered number: 08104785)

Notes to the Consolidated Cash Flow Statement
for the Year Ended 31 March 2025

1. RECONCILIATION OF (LOSS)/PROFIT BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS

Period
1.10.22
Year Ended to
31.3.25 31.3.24
£    £   
(Loss)/profit before taxation (2,881,784 ) 505,491
Depreciation charges 789,589 975,864
Loss on disposal of fixed assets - 18,382
Finance costs 403,940 599,375
Finance income (1,815 ) (14,524 )
(1,690,070 ) 2,084,588
Decrease in stocks 560 106,681
Decrease/(increase) in trade and other debtors 1,168,315 (834,954 )
Increase in trade and other creditors 1,663,801 523,849
Cash generated from operations 1,142,606 1,880,164

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 March 2025
31.3.25 1.4.24
£    £   
Cash and cash equivalents 790,910 419,483
Period ended 31 March 2024
31.3.24 1.10.22
£    £   
Cash and cash equivalents 419,483 223,334


3. ANALYSIS OF CHANGES IN NET DEBT

At 1.4.24 Cash flow At 31.3.25
£    £    £   
Net cash
Cash at bank 419,483 371,427 790,910
419,483 371,427 790,910
Debt
Finance leases (972,723 ) (85,154 ) (1,057,877 )
Debts falling due within 1 year - (248,950 ) (248,950 )
(972,723 ) (334,104 ) (1,306,827 )
Total (553,240 ) 37,323 (515,917 )

Bio Collectors Holdings Limited (Registered number: 08104785)

Notes to the Consolidated Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Bio Collectors Holdings Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the General Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in sterling, which is the functional currency of the group.

The directors have prepared forecast profits and cash flows for the foreseeable future which show the group has sufficient financial headroom to continue to meet its liabilities as they fall due. The financial statements have therefore been prepared on a going concern basis.

Basis of consolidation
All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment or the asset transferred.

Where necessary, adjustments are made to the financial statements to bring the accounting policies used into line with those used by other members of the group.

When control over a subsidiary is lost, its assets, liabilities are derecognised from the consolidated balance sheet. The fair value of the consideration received is recognised, and any retained interest in the former subsidiary is remeasured to its fair value. This retained interest is then classified appropriately as a financial asset, associate, or joint venture depending on the circumstances. A gain or loss on disposal is recognised in the profit or loss statement. This is calculated as the aggregate of the fair value of the consideration received and the fair value of any retained interest, less the carrying amount of the subsidiary’s net assets and any associated goodwill.

Bio Collectors Holdings Limited (Registered number: 08104785)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2025

2. ACCOUNTING POLICIES - continued

Significant judgements and estimates
In the application of the group's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Critical judgements
The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

Tangible fixed assets
Tangible fixed assets are depreciated over their useful lives taking into account residual values, where appropriate. The actual lives of the assets and residual values are assessed annually and may vary depending on a number of factors Residual value assessments consider issues such as the remaining life of the asset and projected disposal values.

Stock provisions
Spare parts equipment is carried as stock and recognised in the profit and loss as consumed where these arc not categorised as major spare parts. Where spare parts are considered to be major and expected to be used during more than one financial period they are accounted for as tangible fixed assets.

Decommissioning provision
As part of the measurement and recognition of assets and liabilities in the period, the group has recognised a provision for the decommissioning obligations associated with the anaerobic digestion plant. In determining the present value of the provision, assumptions and estimates are made in relation to the discount rates, the expected cost to dismantle and remove the plant from the site and the expected timing of these costs, and this data is compared to industry available data. The discount rate applied was 5.13%.

Turnover
Turnover represents the amount derived from the provision of services and the sale of goods which fall within the group's principal activities, carried out entirely within the United Kingdom. Turnover is stated net of value added tax and after deducting trade discounts and any other sales incentives. The fair value of the consideration received or receivable takes into account any trade discounts, settlement discounts and volume-related rebates where applicable.

Income from food waste collection services is recognised either when the food waste is collected from the customer or when the waste container is exchanged, depending on the contractual terms in place and the point at which control of the waste passes to the group. Income from the sale of collected food waste is recognised when legal title and control of the waste is transferred by the group to the anaerobic digestion plant, which is typically upon delivery and acceptance of the food waste by the AD operator. Where food waste is collected from a customer and transferred by the group to a third-party treatment or processing facility, revenue is recognised when control of the waste passes from the group to that third party in accordance with the relevant contractual arrangements.

Government schemes including the Non-Domestic Renewable Heat Incentive and Feed-in Tariff are received as part of the group's trade. This is recognised as turnover when there is reasonable assurance that the conditions have been met and the income will be received.

Bio Collectors Holdings Limited (Registered number: 08104785)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2025

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Assets under construction- not depreciated
Plant and machinery- 15% on reducing balance, straight line over 5 - 20 years

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of fixed assets
At each reporting period end date, the group reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the group estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Bio Collectors Holdings Limited (Registered number: 08104785)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2025

2. ACCOUNTING POLICIES - continued

Financial instruments
The group has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the group's balance sheet when the group becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset. with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Equity instruments
Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Bio Collectors Holdings Limited (Registered number: 08104785)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate.

Comparatives
The comparative period figures relate to the 18-month period ended 31 March 2024 and are therefore not directly comparable with the current period.

Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

3. TURNOVER

The turnover and loss (2024 - profit) before taxation are attributable to the principal activities of the group.

An analysis of turnover by class of business is given below:

Period
1.10.22
Year Ended to
31.3.25 31.3.24
£    £   
Waste collection and recycling 3,009,328 4,023,944
Production of renewable energy 7,431,922 14,143,482
10,441,250 18,167,426

Bio Collectors Holdings Limited (Registered number: 08104785)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2025

4. EMPLOYEES AND DIRECTORS
Period
1.10.22
Year Ended to
31.3.25 31.3.24
£    £   
Wages and salaries 3,214,536 4,630,983
Social security costs 335,119 514,875
Other pension costs 55,247 113,880
3,604,902 5,259,738

The average number of employees during the year was as follows:
Period
1.10.22
Year Ended to
31.3.25 31.3.24

Admin 3 4
Commercial 62 61
65 65

The average number of employees by undertakings that were proportionately consolidated during the year was 65 (2024 - 65 ) .

Period
1.10.22
Year Ended to
31.3.25 31.3.24
£    £   
Directors' remuneration - 181,200
Directors' pension contributions to money purchase schemes - 1,761

5. OPERATING (LOSS)/PROFIT

The operating loss (2024 - operating profit) is stated after charging:

Period
1.10.22
Year Ended to
31.3.25 31.3.24
£    £   
Hire of plant and machinery 261,991 431,716
Other operating leases 73,030 129,737
Depreciation - owned assets 772,090 970,423
Depreciation - assets on hire purchase contracts 17,499 5,441
Loss on disposal of fixed assets - 18,382
Auditors' remuneration 6,000 4,000
Auditors' remuneration for other services 60,242 27,550

Bio Collectors Holdings Limited (Registered number: 08104785)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2025

6. INTEREST PAYABLE AND SIMILAR EXPENSES
Period
1.10.22
Year Ended to
31.3.25 31.3.24
£    £   
Loan interest 296,587 477,605
Finance cost on discounted provision 26,401 34,984
Other interest 13,202 -
Hire purchase 67,750 86,786
403,940 599,375

7. TAXATION

Analysis of the tax (credit)/charge
The tax (credit)/charge on the loss for the year was as follows:
Period
1.10.22
Year Ended to
31.3.25 31.3.24
£    £   
Current tax:
UK corporation tax 34,246 (23,689 )

Deferred tax (751,893 ) 170,022
Tax on (loss)/profit (717,647 ) 146,333

Reconciliation of total tax (credit)/charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

Period
1.10.22
Year Ended to
31.3.25 31.3.24
£    £   
(Loss)/profit before tax (2,881,784 ) 505,491
(Loss)/profit multiplied by the standard rate of corporation tax in the UK of
25 % (2024 - 25 %)

(720,446

)

126,373

Effects of:
Expenses not deductible for tax purposes 7,368 6,077
Adjustments to tax charge in respect of previous periods (11,062 ) (35,322 )
Deferred tax not provided 6,493 50,989
Enhanced capital allowances - (1,784 )
Total tax (credit)/charge (717,647 ) 146,333

8. INDIVIDUAL INCOME STATEMENT

As permitted by Section 408 of the Companies Act 2006, the Income Statement of the parent company is not presented as part of these financial statements.


Bio Collectors Holdings Limited (Registered number: 08104785)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2025

9. DIVIDENDS
Period
1.10.22
Year Ended to
31.3.25 31.3.24
£    £   
Ordinary shares of 10p each
Final - 400,000

10. TANGIBLE FIXED ASSETS

Group
Assets
under Plant and
construction machinery Totals
£    £    £   
COST
At 1 April 2024 345,876 11,623,222 11,969,098
Additions 57,643 765,156 822,799
Reclassification/transfer (403,519 ) 403,519 -
At 31 March 2025 - 12,791,897 12,791,897
DEPRECIATION
At 1 April 2024 - 4,621,140 4,621,140
Charge for year - 789,589 789,589
At 31 March 2025 - 5,410,729 5,410,729
NET BOOK VALUE
At 31 March 2025 - 7,381,168 7,381,168
At 31 March 2024 345,876 7,002,082 7,347,958

Plant and machinery includes a decommissioning provision (see note 19) with a net book value of £311,558 (2024: £244,691).

The net carrying value of tangible fixed assets in respect of assets held under finance leases is £1,608,975 (2024: £1,433,746).

11. FIXED ASSET INVESTMENTS

Company
Shares in
group
undertakings
£   
COST
At 1 April 2024
and 31 March 2025 45,200
NET BOOK VALUE
At 31 March 2025 45,200
At 31 March 2024 45,200

Bio Collectors Holdings Limited (Registered number: 08104785)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2025

11. FIXED ASSET INVESTMENTS - continued

The group or the company's investments at the Balance Sheet date in the share capital of companies include the following:

Subsidiaries

Riverside Bio Limited
Registered office:
Nature of business: Renewable energy production
%
Class of shares: holding
Ordinary 100.00

Riverside AD Limited
Registered office:
Nature of business: Dormant
%
Class of shares: holding
Ordinary 100.00

Bio Collectors Limited
Registered office:
Nature of business: Food waste management
%
Class of shares: holding
Ordinary 100.00

Registered office addresses for all subsidiaries is:

10 Osier Way,
Mitcham,
Surrey,
CR4 4NF


12. STOCKS

Group
31.3.25 31.3.24
£    £   
Stocks 78,711 79,271

13. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
31.3.25 31.3.24 31.3.25 31.3.24
£    £    £    £   
Trade debtors 1,402,453 2,250,751 - -
Amounts owed by group undertakings - - 3,639,116 3,567,951
Other debtors 380,422 142,517 - 25,890
Tax 56,936 91,282 - -
Prepayments and accrued income 901,673 1,459,595 - -
2,741,484 3,944,145 3,639,116 3,593,841

Included in trade debtors is an invoice finance facility amounting to £731,139 (2024: £1,348,223).

Bio Collectors Holdings Limited (Registered number: 08104785)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2025

14. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
31.3.25 31.3.24 31.3.25 31.3.24
£    £    £    £   
Other loans (see note 16) 248,950 - - -
Hire purchase contracts (see note 17) 396,675 296,190 - -
Trade creditors 1,532,019 1,695,689 - -
Amounts owed to group undertakings - - 198,382 180,632
Amounts owed to participating interests 170,873 203,946 170,873 203,946
Social security and other taxes 72,211 104,447 - -
VAT 48,709 - - -
Other creditors 10,375 14,600 100 100
Accruals and deferred income 582,319 388,263 6,000 25,892
3,062,131 2,703,135 375,355 410,570

15. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR

Group Company
31.3.25 31.3.24 31.3.25 31.3.24
£    £    £    £   
Hire purchase contracts (see note 17) 661,202 676,533 - -
Amounts owed to group undertakings 4,837,609 3,183,369 3,287,609 3,183,369
5,498,811 3,859,902 3,287,609 3,183,369

The amounts owed to group undertakings relate to loans from the ultimate parent company which are due for repayment between 31 August 2034 and 30 November 2034. Interest was charged during the year of £296,587 (2024: £477,605) at a rate between 6.5% and 9% per annum. During the year, interest on the loan amounting to £1,550,000 was waived.

16. LOANS

An analysis of the maturity of loans is given below:

Group
31.3.25 31.3.24
£    £   
Amounts falling due within one year or on demand:
Other loans 248,950 -

Other loans include £248,950 (2024:£Nil) owed as part of an invoice factoring facility. Invoice finance is secured by a fixed and floating charge over the group's assets, and interest is charged at 6.75% on amounts owed.

Bio Collectors Holdings Limited (Registered number: 08104785)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2025

17. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Group
Hire purchase
contracts
31.3.25 31.3.24
£    £   
Net obligations repayable:
Within one year 396,675 296,190
Between one and five years 661,202 676,533
1,057,877 972,723

Group
Non-cancellable
operating leases
31.3.25 31.3.24
£    £   
Within one year 120,936 118,565
Between one and five years 616,538 614,166
In more than five years 369,923 493,230
1,107,397 1,225,961

18. PROVISIONS FOR LIABILITIES

Group
31.3.25 31.3.24
£    £   
Deferred tax
Accelerated capital allowances 1,452,266 1,369,193
Tax losses carried forward (833,284 ) -
Other timing differences (1,682 ) -
617,300 1,369,193
Other provisions
Decommissioning provision 634,176 514,635

Aggregate amounts 1,251,476 1,883,828

Group
Deferred Other
tax provisions
£    £   
Balance at 1 April 2024 1,369,193 514,635
Provided during year (751,893 ) 93,140
Unwinding of discounted amount - 26,401
Balance at 31 March 2025 617,300 634,176

Bio Collectors Holdings Limited (Registered number: 08104785)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 31 March 2025

19. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.25 31.3.24
value: £    £   
451,020 Ordinary 10p 45,102 45,102

20. RESERVES

Group
Retained
earnings
£   

At 1 April 2024 3,298,890
Deficit for the year (2,164,137 )
At 31 March 2025 1,134,753

Company
Retained
earnings
£   

Deficit for the year (23,750 )
At 31 March 2025 (23,750 )


21. PENSION COMMITMENTS

The group operates defined contribution pension schemes. The assets of the schemes are held separately from those of the companies in an independently administered fund. The pension cost charge represents contributions payable by the group to the fund and amounted to £58,326 (2024 - £110,801). The pension contributions outstanding at the year end amounted to £10,425 (2024 - £12,934).

22. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Foresight Environmental Infrastructure (UK) Limited, incorporated in England and Wales. The address of its registered office is Foresight Group LLP The Shard, 32 London Bridge Street, London, United Kingdom, SE1 9SG.

The ultimate parent is Foresight Environmental Infrastructure Limited, incorporated in Guernsey, Channel Islands.